We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Panel Recommends Arena’s Obesity Drug Lorcaserin
FDA Panel Recommends Arena’s Obesity Drug Lorcaserin
May 11, 2012
An agency advisory panel voted 18–4 with one abstention Thursday in favor of approval for Arena’s weight-loss drug lorcaserin.